Linde (NYSE:LIN) Price Target Raised to $220.00 at KeyCorp
Linde (NYSE:LIN) had its target price raised by equities researchers at KeyCorp from $205.00 to $220.00 in a research report issued to clients and investors on Tuesday, The Fly reports. The firm presently has an “overweight” rating on the basic materials company’s stock. KeyCorp’s price target would suggest a potential upside of 8.48% from the company’s previous close.
Other research analysts have also recently issued reports about the company. ValuEngine raised Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Monday, April 1st. Argus began coverage on Linde in a research note on Friday, March 22nd. They issued a “hold” rating and a $175.10 target price for the company. Jefferies Financial Group reissued a “buy” rating on shares of Linde in a research note on Friday, June 21st. Zacks Investment Research cut HEXO from a “hold” rating to a “sell” rating in a research note on Wednesday, May 15th. Finally, Societe Generale restated a “buy” rating on shares of Linde in a report on Monday, April 15th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $201.01.
NYSE:LIN traded up $1.04 on Tuesday, reaching $202.81. The company’s stock had a trading volume of 1,225,227 shares, compared to its average volume of 1,751,709. Linde has a 1-year low of $145.95 and a 1-year high of $204.76. The company has a current ratio of 1.35, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The stock’s 50-day moving average price is $196.84.
In related news, CEO Stephen F. Angel sold 56,574 shares of the company’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $197.27, for a total transaction of $11,160,352.98. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Christian Bruch bought 1,474 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The shares were bought at an average price of $179.21 per share, for a total transaction of $264,155.54. The disclosure for this purchase can be found here. Insiders own 0.70% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in LIN. Norges Bank bought a new stake in Linde during the fourth quarter worth about $2,624,717,000. Deutsche Bank AG acquired a new position in Linde during the fourth quarter worth approximately $1,315,604,000. FMR LLC acquired a new position in Linde during the fourth quarter worth approximately $1,245,211,000. Geode Capital Management LLC acquired a new position in Linde during the fourth quarter worth approximately $997,692,000. Finally, Amundi Pioneer Asset Management Inc. increased its position in Linde by 33,491.9% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 4,907,437 shares of the basic materials company’s stock worth $863,366,000 after buying an additional 4,892,828 shares during the last quarter. Institutional investors and hedge funds own 72.84% of the company’s stock.
Linde plc operates as an industrial gas company in primarily North and South America, Europe, the Middle East, Africa, the Asia Pacific, and South Korea. The company offers oxygen, nitrogen, argon, rare gases, carbon monoxide, carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Recommended Story: Net Margin
Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.